Study Summary
This trial is looking at whether an internet-based app can help improve adherence to a cancer treatment regimen.
- Breast
- erbB-2 Receptor
- Hormone Receptor-Positive Breast Carcinoma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 2 Secondary · Reporting Duration: Up to 1 year
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Single Arm (internet intervention, best practice)
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Best Practice · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 26th, 2021
Last Reviewed: November 24th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.